Local free light chain expression is increased in chronic rhinosinusitis with nasal polyps

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 67, Issue 9, 2012, Pages 1165-1172

  Kormelink, T Groot ^a   Calus, L ^b   De Ruyck, N ^b   Holtappels, G ^b   Bachert, C ^b   Redegeld, F A ^a   Gevaert, P ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

anti IL 5; chronic rhinosinusitis; immunoglobulin free light chain; mast cell; nasal polyposis

Indexed keywords

DOXYCYCLINE; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; INTERLEUKIN 5; MEPOLIZUMAB; METHYLPREDNISOLONE; PLACEBO;

ARTICLE; CHRONIC RHINOSINUSITIS; CHRONIC RHINOSINUSITIS WITH NASAL POLYP; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAST CELL; NOSE MUCOSA; NOSE POLYP; NOSE SECRETION; PARANASAL SINUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERUM; TH2 CELL; TISSUE HOMOGENATE;

CHRONIC DISEASE; FEMALE; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; INTERLEUKIN-5; MALE; MAST CELLS; NASAL MUCOSA; NASAL POLYPS; RHINITIS; SINUSITIS;

EID: 84864984020     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2012.02866.x     Document Type: Article

References (37)

1. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. EPOS 2012: European position paper on rhinosinusitis nasalpolyps 2012. A summary for otorhinolaryngologists. Rhinology 2012; 50: 1-12.
2. Van Zele T, Claeys S, Gevaert P, Van Maele G, Holtappels G, Van Cauwenberge P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 2006; 61: 1280-1289.
3. Van Bruaene N, Perez-Novo CA, Basinski TM, Van Zele T, Holtappels G, De Ruyck N, et al. T-cell regulation in chronic paranasal sinus disease. J Allergy Clin Immunol 2008; 121: 1435-1441, 1441 e1431-1433.
4. Gevaert P, Holtappels G, Johansson SG, Cuvelier C, Cauwenberge P, Bachert C,. Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue. Allergy 2005; 60: 71-79.
5. Van Zele T, Gevaert P, Watelet JB, Claeys G, Holtappels G, Claeys C, et al. Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol 2004; 114: 981-983.
6. Galli SJ, Grimbaldeston M, Tsai M,. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 2008; 8: 478-486.
7. Patou J, Holtappels G, Affleck K, van Cauwenberge P, Bachert C,. Syk-kinase inhibition prevents mast cell activation in nasal polyps. Rhinology 2011; 49: 100-106.
8. Zhang N, Holtappels G, Gevaert P, Patou J, Dhaliwal B, Gould H, et al. Mucosal tissue polyclonal IgE is functional in response to allergen and SEB. Allergy 2011; 66: 141-148.
9. Pawankar R,. Mast cells in allergic airway disease and chronic rhinosinusitis. Chem Immunol Allergy 2005; 87: 111-129.
10. Takabayashi T, Kato A, Peters AT, Suh LA, Carter R, Norton J, et al. Glandular mast cells with distinct phenotype are highly elevated in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 2012. http://dx.doi.org/10.1016/j.jaci.2012.02.046.
11. Otsuka H, Ohkubo K, Seki H, Ohnishi M, Fujikura T,. Mast cell quantitation in nasal polyps, sinus mucosa and nasal turbinate mucosa. J Laryngol Otol 1993; 107: 418-422.
12. Bachert C, Gevaert P, Holtappels G, Johansson SG, van Cauwenberge P,. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001; 107: 607-614.
13. Kitapci F, Muluk NB, Atasoy P, Koc C,. Role of mast and goblet cells in the pathogenesis of nasal polyps. J Otolaryngol 2006; 35: 122-132.
14. Soler ZM, Sauer DA, Mace J, Smith TL,. Relationship between clinical measures and histopathologic findings in chronic rhinosinusitis. Otolaryngol Head Neck Surg 2009; 141: 454-461.
15. Shaw JL, Ashoori F, Fakhri S, Citardi MJ, Luong A,. Increased percentage of mast cells within sinonasal mucosa of chronic rhinosinusitis with nasal polyp patients independent of atopy. Int Forum Allergy Rhinol 2012; 2: 233-240.
16. Redegeld FA, van der Heijden MW, Kool M, Heijdra BM, Garssen J, Kraneveld AD, et al. Immunoglobulin-free light chains elicit immediate hypersensitivity-like responses. Nat Med 2002; 8: 694-701.
17. Powe DG, Groot Kormelink T, Sisson M, Blokhuis BJ, Kramer MF, Jones NS, et al. Evidence for the involvement of free light chain immunoglobulins in allergic and nonallergic rhinitis. J Allergy Clin Immunol 2010; 125: 139-145 E131-133.
18. Kraneveld AD, Kool M, van Houwelingen AH, Roholl P, Solomon A, Postma DS, et al. Elicitation of allergic asthma by immunoglobulin free light chains. Proc Natl Acad Sci USA 2005; 102: 1578-1583.
19. Groot Kormelink T, Tekstra J, Thurlings RM, Boumans MH, Vos K, Tak PP, et al. Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activity. Ann Rheum Dis 2010; 69: 2137-2144.
20. Rinker JR, 2nd, Trinkaus K, Cross AH,. Elevated CSF free kappa light chains correlate with disability prognosis in multiple sclerosis. Neurology 2006; 67: 1288-1290.
21. Gottenberg JE, Aucouturier F, Goetz J, Sordet C, Jahn I, Busson M, et al. Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome. Ann Rheum Dis 2007; 66: 23-27.
22. Groot Kormelink T, Askenase PW, Redegeld FA,. Immunobiology of antigen-specific immunoglobulin free light chains in chronic inflammatory diseases. Curr Pharm Des 2012; 18: 2278-2289.
23. Gevaert P, Van Bruaene N, Cattaert T, Van Steen K, Van Zele T, Acke F, et al. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol 2011; 128: 989-995 e981-988.
24. Van Zele T, Gevaert P, Holtappels G, Beule A, Wormald PJ, Mayr S, et al. Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol 2010; 125: 1069-1076 e1064.
25. Abe M, Goto T, Kosaka M, Wolfenbarger D, Weiss DT, Solomon A,. Differences in kappa to lambda (kappa:lambda) ratios of serum and urinary free light chains. Clin Exp Immunol 1998; 111: 457-462.
26. Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR, et al. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem 2002; 48: 1437-1444.
27. Van Zele T, Gevaert P, Holtappels G, van Cauwenberge P, Bachert C,. Local immunoglobulin production in nasal polyposis is modulated by superantigens. Clin Exp Allergy 2007; 37: 1840-1847.
28. Amin K, Rinne J, Haahtela T, Simola M, Peterson CG, Roomans GM, et al. Inflammatory cell and epithelial characteristics of perennial allergic and nonallergic rhinitis with a symptom history of 1 to 3 years' duration. J Allergy Clin Immunol 2001; 107: 249-257.
29. Patou J, Holtappels G, Affleck K, Gevaert P, Perez-Novo C, Van Cauwenberge P, et al. Enhanced release of IgE-dependent early phase mediators from nasal polyp tissue. J Inflamm (Lond) 2009; 6: 11.
30. Blokhuis BR, Thio M, Redegeld FA,. Immunoglobulin free light chains synergistically enhance IgE-mediated mast cell activation. Allergy 2011; 66: 498.
31. Kuzin, II, Snyder JE, Ugine GD, Wu D, Lee S, et al. Tetracyclines inhibit activated B cell function. Int Immunol 2001; 13: 921-931.
32. Kouro T, Takatsu K,. IL-5- and eosinophil-mediated inflammation: from discovery to therapy. Int Immunol 2009; 21: 1303-1309.
33. Gevaert P, Lang-Loidolt D, Lackner A, Stammberger H, Staudinger H, Van Zele T, et al. Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps. J Allergy Clin Immunol 2006; 118: 1133-1141.
34. Takatsu K, Kouro T, Nagai Y,. Interleukin 5 in the link between the innate and acquired immune response. Adv Immunol 2009; 101: 191-236.
35. Groot Kormelink T, Pardo A, Knipping K, Buendia-Roldan I, Garcia-de-Alba C, Blokhuis BR, et al. Immunoglobulin free light chains are increased in hypersensitivity pneumonitis and idiopathic pulmonary fibrosis. PLoS ONE 2011; 6: e25392.
36. Hannam-Harris AC, Smith JL,. Induction of balanced immunoglobulin chain synthesis in free light chain-producing lymphocytes by mitogen stimulation. J Immunol 1981; 126: 1848-1851.
37. Ambrosino DM, Kanchana MV, Delaney NR, Finberg RW,. Human B cells secrete predominantly lambda L chains in the absence of H chain expression. J Immunol 1991; 146: 599-602.